Brief: Onward Medical Reports Interim Clinical Outcomes For Implantable ARC Therapy

ONWARD Medical

08/12/2022 06:35

Dec 8 (Reuters) - Onward Medical NV  ONWD.BR :
    * ONWARD REPORTS INTERIM CLINICAL OUTCOMES FOR IMPLANTABLE
ARC
THERAPY DEMONSTRATING POTENTIAL TO IMPROVE BLOOD PRESSURE
REGULATION AFTER SPINAL CORD INJURY
    * ARC THERAPY IMMEDIATELY IMPROVED BLOOD PRESSURE LEVELS FOR
ALL
PARTICIPANTS
    * THIS BENEFIT HAS BEEN SUSTAINED FOR DURATION OF CURRENT
FOLLOW-UP PERIOD
    * ONWARD IS PREPARING TO INITIATE FURTHER CLINICAL TRIALS TO
INCLUDE U.S. PARTICIPANTS IN 2023
    * ONWARD IS PREPARING TO INITIATE FURTHER CLINICAL TRIALS TO
INCLUDE U.S. PARTICIPANTS IN 2023
    * PARTICIPANTS ALSO REPORTED IMPROVED GENERAL WELL-BEING:
PARTICIPANTS REPORTED A REDUCTION IN ORTHOSTATIC HYPOTENSION,
INCLUDING REDUCED DIZZINESS AND IMPROVED ENERGY
    * INTERIM RESULTS REPORTED TODAY INVOLVE TEN PEOPLE WITH
SPINAL
CORD INJURY, WERE TREATED AT CLINICAL CENTRES IN CANADA, TREATED
AT CLINICAL CENTRES IN CANADA AND SWITZERLAND

Source text for Eikon:  ID:nBw2FNyY6a 
Further company coverage:  ONWD.BR 
 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))